Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/cancerbiology.2.020
Surgery Versus Radiation Therapy for Early-Stage Lung Cancer: Patient Selection is Crucial
Matthew T. Hey1, Hans E. Drawbert1, Francisco Tarrazzi1,2, Mark Block1,2, Syed S. Razi1,2,*
- 1Florida International University Herbert Wertheim College of Medicine, Miami, Florida, USA
- 2Division of Thoracic Surgery, Memorial Healthcare System, Hollywood, Florida, USA
Corresponding Author
Syed S. Razi, SRazi@mhs.net; SRazi@fiu.edu
Received Date: April 24, 2021
Accepted Date: May 28, 2021
Hey MT, Drawbert HE, Tarrazzi F, Block M, Razi SS. Surgery Versus Radiation Therapy for Early-Stage Lung Cancer: Patient Selection Is Crucial. Arch Cancer Biol Ther. 2021; 2(1): 25-28.
Copyright: © 2021 Hey MT, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Lung cancer, Lobectomy, Stereotactic body radiation therapy, Thoracic surgery, Quality care, Outcomes, Cancer treatment, Patient selection
Recommended Articles
Uniportal VATS Lobectomy for Lung Cancer: Feasibility and Cost Effectiveness in a Single Center Experience
In last decades, video-assisted thoracic surgery (VATS) together with robotic-assisted thoracic surgery (RATS) can be considered the biggest innovation in thoracic surgery. This approach drastically changed the way of performing surgical operations, improving patient’s outcome undergoing thoracic surgery.
Botulinum Toxin: The Promising Future of Prostate Cancer Treatment
Peripheral nerves have been shown to modulate the growth and spread of tumours in the prostate, feeding both cancer cells and the stroma in the tumour environment. Several in vitro and in vivo studies have reported the effect of botulinum toxin (BT) on tumour tissue in the prostate. BT in humans has been observed to cause increased apoptosis of cancer cells, with morphological changes characterized by extensive degenerative and atrophic areas of cancer, reduced cytoplasm, and pyknotic nuclei, compared to the characteristics of cancer tissues injected with saline solution.
Surgery Versus Radiation Therapy for Early-Stage Lung Cancer: Patient Selection is Crucial
Lung cancer remains the leading cause of cancer related death in the United States with mortality rates surpassing breast, prostate, brain, and colorectal cancers combined. Recent data shows that susceptibility for both men and women for developing invasive lung and bronchogenic carcinoma peak after the age of 70 years.
NOXA the BCL-2 Family Member behind the Scenes in Cancer Treatment
NOXA is a critical mediator of stress responses to anticancer drugs. This BH3-only protein sets the apoptotic threshold in cancer cells in response to chemotherapies by counteracting the prosurvival BCL-2 family protein MCL-1. A complex and dynamic network relying on both highly controlled gene transcription activity and protein degradation by proteasome, regulates cellular NOXA levels from low in steady state to rapidly enhanced upon stressful condition.
High Lymph Node Positive to Sampled Ratio as a Potential Indication for Postoperative Radiation Therapy in Patients with pN2 Non-small-cell Lung Cancer
The role for postoperative radiation therapy (PORT) for patients with non–small-cell lung cancer (NSCLC) with mediastinal lymph node (LN) involvement (pN2 disease) is controversial. We performed a SEER analysis comparing surgery alone with PORT among patients with pN2 NSCLC. As we await the final results of the LUNG ART trial, a subset of patients with a high LN positive to sampled (LPR) ratio may benefit from PORT.